End Stage Liver Disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients of both gender; age between 18 and 70 years; with 1 month post liver transplantation; who present clinical conditions to perform the proposed procedures
Exclusion criteria
Exclusion criteria: Patients with post-transplant liver encephalopathy; cognitive changes that make it difficult to answer the questionnaires; patients who underwent surgical reintervention less than 1 month after the transplant; those who have clinical changes observed in complementary exams; graft rejection; difficulty in walking and orthopedic limitations that make it impossible to carry out the six-minute walk tests and step test and participation in the physical activity program and patients with severe cardiovascular disease who contraindicated exercise
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Significant increase of the functional capacity from the increase of the walked distance in the six-minute walking test after 8 weeks of the intervention protocol. | — |
Secondary
| Measure | Time frame |
|---|---|
| Significant improvement in the quality of life using the quality of life questionnaires (SF-36) after 8 weeks of the intervention protocol. ;Significant decrease in the anxiety and depression score punctuation using the Hospital Anxiety and Depression Scale after 8 weeks of the intervention protocol. ;Significant improvement of respiratory muscle strength using manovacuometry and the maximum strength of upper limb, using the one maximum repetition after 8 weeks of the intervention protocol. ;Significant improvement of fatigue and dyspnea using the fatigue severity scale and the modified dyspnea index (MMRC) and sleep by Pittsburgh Sleep Quality Index (PSQI) after 8 weeks of the intervention protocol. | — |
Countries
Brazil